Social and ethical implications of HIV cure research

AIDS

Volumn 28, Issue 9, 2014, Pages 1247-1250

  Tucker, Joseph D ^a,b,c   Rennie, Stuart ^a,c   Bangsberg, David ^c   Cai, Weiping ^c   Cheng, Ben ^c   Crane, Johanna ^c   de Roubaix, Malcolm ^c   Fenton, Kevin ^c   Gelpi, Adriane ^c   Henderson, Gail ^c   Hightow Weidman, Lisa ^c   Lo, Ying Ru ^c   Meier, Benjamin M ^c   Margolis, David ^c   Moodley, Keymanthri ^c   Necochea, Raul ^c   Nie, Jing Bao ^c   Isler, Malika Roman ^c   Siedner, Mark J ^c   Rossouw, Theresa ^c   Sugarman, Jeremy ^c   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNC Project China   (China)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; DISEASE CONTROL; DISEASE ERADICATION; EMPIRICAL RESEARCH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ETHICS; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIAL ASPECT; ETHICS; HEALTH CARE POLICY; HIV INFECTIONS; MEDICAL INFORMATION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PROCEDURES; PSYCHOLOGY; TRENDS;

BIOMEDICAL RESEARCH; DISEASE ERADICATION; HEALTH COMMUNICATION; HEALTH POLICY; HIV INFECTIONS; HUMANS;

EID: 84922479914     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000210     Document Type: Note

References (24)

1. Sontag S. AIDS and its metaphors. 1st ed. New York: Farrar, Straus and Giroux; 1989.
2. Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med 1991; 324:1500-1504.
3. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360: 692-698.
4. Henrich T, Hanhauser E, Sirignano M, Davis B, Lee T-H, Keating S, et al. In depth investigation of peripheral and gut HIV-1 reservoirs, HIV-specific cellular immunity, and host microchimerism following allogeneic hematopoetic stem cell transplantation. 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, 3 July 2013; Kuala Lumpur, Malaysia. pp. WELBA05.
5. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak TWC, Strain M, et al. Functional HIV cure after very early ART of an infected infant. Conference on Retroviruses and Opportunistic Infections, 3 March 2013; Georgia World Congress Center, Atlanta, GA.
6. Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, et al. Posttreatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9:e1003211.
7. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 2013; 381:2109-2117.
8. Lewin SR. A cure for HIV: where we've been, and where we're headed. Lancet 2013; 381:2057-2058.
9. Rosenberg C. The therapeutic revolution: medicine, meaning and social change in nineteenth century America. Perspect Biol Med 1977; 4:485-506.
10. Kippax S. Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc 2012; 15:17357.
11. Beaney M. The Stanford encyclopedia of philosophy. Stanford, CT: Center for the Study of Language and Information, Stanford University; 2003.
12. Oxford University Press. Concise Oxford English dictionary [CD-ROM]. 11th ed. Rev. Oxford, New York: Oxford University Press; 2006.
13. Brandt AM. No magic bullet: a social history of venereal disease in the United States since 1880. Expanded ed. New York: Oxford University Press; 1987.
14. Amon JJ. Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs. Global Health 2008; 4:5.
15. Cassidy R, Leach M. Science, politics, and the presidential AIDS 'cure'. Afr Aff 2009; 108:559-580.
16. Obadare E, Okeke IN. Biomedical loopholes, distrusted state, and the politics of HIV/AIDS 'cure' in Nigeria. Afr Aff (Lond) 2011; 110:191-211.
17. Anderson OW. Syphilis and society: problems of control in the United States, 1912-1964. In: Studies CIHA. Chicago: University of Chicago; 1965. pp. 1-62.
18. Lo B, Grady C, Working Group on Ethics of the International AS. Ethical considerations in HIV cure research: points to consider. Curr Opin HIV AIDS 2013; 8:243-249.
19. Sugarman J. HIV cure research: expanding the ethical considerations. Ann Intern Med 2013[Epub ahead of print].
20. Menezes P, Eron JJ Jr, Leone PA, Adimora AA, Wohl DA, Miller WC. Recruitment of HIV/AIDS treatment-naive patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race. HIV Med 2011; 12:183-191.
21. Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 2007; 4:e324.
22. Merton R. The unanticipated consequences of purposive social action. Am Soc Rev 1936; 6:895.
23. Crane JT. Scrambling for Africa: AIDS, expertise, and the rise of American Global Health Science. Ithaca: Cornell University Press; 2013.
24. MacNeil JM, Anderson S. Beyond the dichotomy: linking HIV prevention with care. AIDS 1998; 12 (Suppl 2):S19-S26.